Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations
Publication in refereed journal


摘要As coronavirus disease 2019 (COVID-19) spreads across the world, the intensive care unit (ICU) community must prepare for the challenges associated with this pandemic. Streamlining of workflows for rapid diagnosis and isolation, clinical management, and infection prevention will matter not only to patients with COVID-19, but also to health-care workers and other patients who are at risk from nosocomial transmission. Management of acute respiratory failure and haemodynamics is key. ICU practitioners, hospital administrators, governments, and policy makers must prepare for a substantial increase in critical care bed capacity, with a focus not just on infrastructure and supplies, but also on staff management. Critical care triage to allow the rationing of scarce ICU resources might be needed. Researchers must address unanswered questions, including the role of repurposed and experimental therapies. Collaboration at the local, regional, national, and international level offers the best chance of survival for the critically ill.
著者Phua J, Weng L, Ling L, Egi M, Lim CM, Divatia JV, Shrestha BR, Arabi YM, Ng J, Gomersall CD, Nishimura M, Koh Y, Du B, Asian Critical Care Clinical Trials Group
期刊名稱Lancet Respiratory Medicine
出版作品名稱The Lancet Respiratory Medicine
詳細描述The Correction to this article has been published in Lancet Respir Med 2020 8(5):e42 - "In this Review, the second sentence in the last paragraph of the Epidemiology and clinical features of critically ill patients section should read “Small, single-ICU studies found mortality rates of 62% (in Wuhan, China) and 67% (in Washington State, USA), but these figures had not accounted for many who were still in the ICU.” This correction has been made to the online version as of May 4, 2020, and the printed version is correct."
頁次506 - 517

上次更新時間 2020-20-09 於 00:58